4//SEC Filing
NOYES TIMOTHY P 4
Accession 0001415889-24-011144
CIK 0001798749other
Filed
Apr 17, 8:00 PM ET
Accepted
Apr 18, 6:00 PM ET
Size
10.9 KB
Accession
0001415889-24-011144
Insider Transaction Report
Form 4
NOYES TIMOTHY P
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2024-04-16$2.14/sh+10,000$21,400→ 10,000 total - Sale
Common Stock
2024-04-16$24.40/sh−4,491$109,561→ 5,509 total - Sale
Common Stock
2024-04-16$24.94/sh−5,509$137,410→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-04-16−10,000→ 363,381 totalExercise: $2.14Exp: 2031-04-01→ Common Stock (10,000 underlying)
Footnotes (4)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 27, 2023.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.80 to $24.785, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.81 to $25.10, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F4]A total of 493,381 shares subject to an employee stock option were granted on April 2, 2021, with 25% vested on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.
Documents
Issuer
Aerovate Therapeutics, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001185035
Filing Metadata
- Form type
- 4
- Filed
- Apr 17, 8:00 PM ET
- Accepted
- Apr 18, 6:00 PM ET
- Size
- 10.9 KB